Bio View

Bio View EBIT Margin

The EBIT Margin (Operating Margin) of Bio View (BIOV.TA) as of Oct 18, 2026 is -39.82 %. In the previous year, EBIT Margin (Operating Margin) was -11.21 % — a change of 255.20% (lower).

EBIT Margin

-39.82 %

YoY

255.20%

Last updated:

EBIT Margin (Operating Margin) of Bio View is 2025 -39.82 % . EBIT Margin (Operating Margin) of Bio View was 2024 -11.21 % . It decreases by 255.20% lower compared to the previous year.

For Bio View, the operating (EBIT) margin of -39.8% is down versus 9.7% a few years ago.

The Bio View EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-6.98 ILS
Jan 1, 2019
9.49 ILS
Jan 1, 2020
4.63 ILS
Jan 1, 2021
9.67 ILS
Jan 1, 2022
4.90 ILS
Jan 1, 2023
2.20 ILS
Jan 1, 2024
-11.21 ILS
Jan 1, 2025
-39.82 ILS
The Bio View EBIT Margin history
YEAREBIT MarginYoY
-39.82 %+255.20%
-11.21 %-608.81%
2.20 %-55.00%
4.90 %-49.36%
9.67 %+108.98%
4.63 %-51.23%
9.49 %-235.87%
-6.98 %+37.17%
-5.09 %-135.78%
14.23 %+27.78%
11.13 %+34.10%
8.30 %-17,591.80%
-0.05 %-171.97%
0.07 %-56.05%
0.15 %-1.27%
0.15 %+78.05%
0.09 %-118.63%
-0.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

EBIT Margin (Operating Margin) of Bio View is -39.82 % in 2025.

EBIT Margin (Operating Margin) of Bio View changed from -11.21 % to -39.82 %, representing a 255.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bio View since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bio View with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bio View

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bio View